Note: This document has been translated from the Japanese original for reference purposes only. In the event ofany discrepancy between this translated document and the Japanese original, the original shall prevail.

February 9, 2023
CompanyHeadquarters
Representative
Contact
Telephone
WebsiteTakara Bio Inc. (Securities code: 4974;Prime Market)
Nojihigashi 7-4-38, Kusatsu, Shiga, Japan
Koichi Nakao, President & CEO
Takuya Kakemi, Executive Officer, in chargeof PR & IR Department(+81)77-565-6970
https://www.takara-bio.co.jp/Notice Concerning Revisions to the Financial Results Forecasts
and Dividend Forecasts (Dividend Increase)

Takara Bio Inc. (the “Company”) hereby announces that in the light of the most recent operating trends, to revise
the financial results forecasts for the fiscal year ending March 31, 2023 (April 1, 2022 – March 31, 2023), disclosed
on November 10, 2022, and the year-end dividend forecasts for the year ending March 31, 2023, as described
below.

1. Revisions to financial results forecasts(1) Revisions to consolidated financial results forecasts for the full year of the current fiscal year (April 1, 2022
through March 31, 2023)
Net sales

OperatingprofitOrdinary
profit

Net income
attributable toowners of the parent

Net income
per share

Million yen

Million yen

Million yen

Million yen

Yen

Previously announced
forecasts (A)77,80019,00019,10013,800114.60

Revised forecasts (B)78,70020,00020,10014,500120.42

Change (B-A)

900

1,000

1,000

700

-

Change (%)

1.2

5.3

5.2

5.1

-

67,69928,90228,45919,849164.84(Reference)
Actualconsolidated results
for the previous fiscalyear (Fiscal year
ended March 31,2022)

(2) Reason for revisionIn net sales, although CDMO and Instruments are expected to be lower than previously announced, sales ofReagents related to the new Coronavirus testing are expected to increase, and Gene Therapy is also expected
to be higher than previously announced. As gross profit is expected to increase due to the increase in sales,operating profit, ordinary profit, and net income attributable to owners of the parent are also expected toexceed the previously announced forecasts. For the reason, the forecasts of the consolidated financial results
for the full year have been revised.
For details of the forecasts announced this time, please refer to page 12 of the “Consolidated Financial
Results for the Nine Months Ended December 31, 2022 (Under Japanese GAAP)” announced today.

2. Revisions to dividend forecasts(1) Details of revision
Annual dividends (Yen)
Second quarter-end

Fiscal-year end

Total

Previous forecasts

40.00

40.00

Revised forecasts

42.00

42.00

33.00

33.00

Actual results for the current fiscal year
Actual results for the previous fiscal year
(Fiscal year ended March 31, 2022)

0.00
0.00

(2) Reason for revision
The Company considers returning profits to shareholders to be an important management issue, while paying
attention to enhancing internal reserves in order to actively implement R&D activities. Our basic policy is toreturn profits to shareholders based on a comprehensive consideration of our operating results and financialposition. Specifically, the Company's policy is to pay dividends from retained earnings of the high 30% rangeof the estimated net income, which is calculated without taking into account extraordinary gains and losses in
the consolidated financial statements.
Based on the above upward revision of the full-year consolidated financial forecast and the above shareholder
return policy, the Company has revised the year-end dividend forecasts for the year ending March 31, 2023 from¥40.00 to ¥42.00 per share.
The year-end dividend for the fiscal year ending March 31, 2023 is scheduled to be discussed at the 21 st
Ordinary General Meeting of Shareholders to be held in June 2023.

Forward-Looking Statements
Statements contained in these materials with respect to the Company’s current plans, forecasts, strategies and beliefs that are
not historical facts are forward-looking statements about the further performance of the Company and its consolidated
subsidiaries. These statements are based on management’s assumptions and beliefs in light of information currently available
to it, but are based on a number of assumptions and beliefs derived from information that contains significant risks anduncertainties. Actual results may differ materially from these forecasts due to various factors. Factors that could influence
actual results include, but are not limited to, economic conditions, especially trends in consumer spending, as well asexchange rate fluctuations, changes in laws and government systems, pressure from competitors’ prices and productstrategies, declines in selling power of the Company’s existing and new products, disruptions to production, violations of ourintellectual property rights, rapid advances in technology, and unfavorable verdicts in major litigation.